vs
Pennant Group, Inc.（PNTG）与RAMBUS INC（RMBS）财务数据对比。点击上方公司名可切换其他公司
Pennant Group, Inc.的季度营收约是RAMBUS INC的1.6倍（$289.3M vs $180.2M），RAMBUS INC净利率更高（33.2% vs 3.0%，领先30.3%），Pennant Group, Inc.同比增速更快（53.2% vs 8.1%），过去两年Pennant Group, Inc.的营收复合增速更高（35.8% vs 16.8%）
Pennant Group, Inc.是一家总部位于美国的医疗服务企业，主营家庭健康护理、临终关怀、长者居住服务及专业护理服务，业务覆盖美国数十个州，核心服务对象为老年及有特殊医疗需求的弱势人群。
Rambus Inc.是创立于1990年的美国科技企业，专注于芯片接口技术与架构的设计、研发及授权，相关技术广泛应用于各类数字电子产品。公司因发明RDRAM内存技术而闻名，在知识产权领域拥有深厚积累。
PNTG vs RMBS — 直观对比
营收规模更大
PNTG
是对方的1.6倍
$180.2M
营收增速更快
PNTG
高出45.1%
8.1%
净利率更高
RMBS
高出30.3%
3.0%
两年增速更快
PNTG
近两年复合增速
16.8%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $289.3M | $180.2M |
| 净利润 | $8.6M | $59.9M |
| 毛利率 | — | 79.7% |
| 营业利润率 | 6.0% | 34.3% |
| 净利率 | 3.0% | 33.2% |
| 营收同比 | 53.2% | 8.1% |
| 净利润同比 | 50.0% | -7.3% |
| 每股收益（稀释后） | $0.25 | $0.55 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PNTGRMBS
| Q1 26 | — | $180.2M | ||
| Q4 25 | $289.3M | $190.2M | ||
| Q3 25 | $229.0M | $178.5M | ||
| Q2 25 | $219.5M | $172.2M | ||
| Q1 25 | $209.8M | $166.7M | ||
| Q4 24 | $188.9M | $161.1M | ||
| Q3 24 | $180.7M | $145.5M | ||
| Q2 24 | $168.7M | $132.1M |
净利润PNTGRMBS
| Q1 26 | — | $59.9M | ||
| Q4 25 | $8.6M | $63.8M | ||
| Q3 25 | $6.1M | $48.4M | ||
| Q2 25 | $7.1M | $57.9M | ||
| Q1 25 | $7.8M | $60.3M | ||
| Q4 24 | $5.8M | $62.2M | ||
| Q3 24 | $6.2M | $48.7M | ||
| Q2 24 | $5.7M | $36.1M |
毛利率PNTGRMBS
| Q1 26 | — | 79.7% | ||
| Q4 25 | — | 78.9% | ||
| Q3 25 | — | 79.5% | ||
| Q2 25 | — | 79.8% | ||
| Q1 25 | — | 80.3% | ||
| Q4 24 | — | 80.4% | ||
| Q3 24 | — | 80.7% | ||
| Q2 24 | — | 79.7% |
营业利润率PNTGRMBS
| Q1 26 | — | 34.3% | ||
| Q4 25 | 6.0% | 37.2% | ||
| Q3 25 | 4.5% | 35.4% | ||
| Q2 25 | 5.3% | 36.6% | ||
| Q1 25 | 6.0% | 37.9% | ||
| Q4 24 | 4.9% | 35.9% | ||
| Q3 24 | 6.0% | 37.6% | ||
| Q2 24 | 5.7% | 30.5% |
净利率PNTGRMBS
| Q1 26 | — | 33.2% | ||
| Q4 25 | 3.0% | 33.6% | ||
| Q3 25 | 2.7% | 27.1% | ||
| Q2 25 | 3.2% | 33.6% | ||
| Q1 25 | 3.7% | 36.2% | ||
| Q4 24 | 3.0% | 38.6% | ||
| Q3 24 | 3.4% | 33.4% | ||
| Q2 24 | 3.4% | 27.3% |
每股收益（稀释后）PNTGRMBS
| Q1 26 | — | $0.55 | ||
| Q4 25 | $0.25 | $0.58 | ||
| Q3 25 | $0.17 | $0.44 | ||
| Q2 25 | $0.20 | $0.53 | ||
| Q1 25 | $0.22 | $0.56 | ||
| Q4 24 | $0.16 | $0.57 | ||
| Q3 24 | $0.20 | $0.45 | ||
| Q2 24 | $0.18 | $0.33 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $134.3M |
| 总债务越低越好 | $168.8M | — |
| 股东权益账面价值 | $374.3M | — |
| 总资产 | $968.2M | $1.5B |
| 负债/权益比越低杠杆越低 | 0.45× | — |
8季度趋势，按日历期对齐
现金及短期投资PNTGRMBS
| Q1 26 | — | $134.3M | ||
| Q4 25 | — | $182.8M | ||
| Q3 25 | — | $79.2M | ||
| Q2 25 | — | $87.8M | ||
| Q1 25 | — | $132.2M | ||
| Q4 24 | — | $99.8M | ||
| Q3 24 | — | $114.0M | ||
| Q2 24 | — | $124.6M |
总债务PNTGRMBS
| Q1 26 | — | — | ||
| Q4 25 | $168.8M | — | ||
| Q3 25 | $26.0M | — | ||
| Q2 25 | $37.0M | — | ||
| Q1 25 | $52.5M | — | ||
| Q4 24 | $0 | — | ||
| Q3 24 | $108.9M | — | ||
| Q2 24 | $82.2M | — |
股东权益PNTGRMBS
| Q1 26 | — | — | ||
| Q4 25 | $374.3M | $1.4B | ||
| Q3 25 | $343.0M | $1.3B | ||
| Q2 25 | $333.6M | $1.2B | ||
| Q1 25 | $323.0M | $1.2B | ||
| Q4 24 | $312.0M | $1.1B | ||
| Q3 24 | $187.3M | $1.0B | ||
| Q2 24 | $173.0M | $1.0B |
总资产PNTGRMBS
| Q1 26 | — | $1.5B | ||
| Q4 25 | $968.2M | $1.5B | ||
| Q3 25 | $753.6M | $1.4B | ||
| Q2 25 | $751.4M | $1.5B | ||
| Q1 25 | $743.6M | $1.4B | ||
| Q4 24 | $679.5M | $1.3B | ||
| Q3 24 | $646.8M | $1.3B | ||
| Q2 24 | $602.5M | $1.3B |
负债/权益比PNTGRMBS
| Q1 26 | — | — | ||
| Q4 25 | 0.45× | — | ||
| Q3 25 | 0.08× | — | ||
| Q2 25 | 0.11× | — | ||
| Q1 25 | 0.16× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.58× | — | ||
| Q2 24 | 0.48× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $21.0M | — |
| 自由现金流经营现金流 - 资本支出 | $17.4M | — |
| 自由现金流率自由现金流/营收 | 6.0% | — |
| 资本支出强度资本支出/营收 | 1.2% | — |
| 现金转化率经营现金流/净利润 | 2.43× | — |
| 过去12个月自由现金流最近4个季度 | $36.3M | — |
8季度趋势，按日历期对齐
经营现金流PNTGRMBS
| Q1 26 | — | — | ||
| Q4 25 | $21.0M | $99.8M | ||
| Q3 25 | $13.9M | $88.4M | ||
| Q2 25 | $34.6M | $94.4M | ||
| Q1 25 | $-21.2M | $77.4M | ||
| Q4 24 | $20.6M | $59.0M | ||
| Q3 24 | $7.7M | $62.1M | ||
| Q2 24 | $10.5M | $70.4M |
自由现金流PNTGRMBS
| Q1 26 | — | — | ||
| Q4 25 | $17.4M | $93.3M | ||
| Q3 25 | $10.5M | $82.5M | ||
| Q2 25 | $31.6M | $87.9M | ||
| Q1 25 | $-23.2M | $69.5M | ||
| Q4 24 | $17.2M | $52.5M | ||
| Q3 24 | $6.8M | $52.2M | ||
| Q2 24 | $8.9M | $59.1M |
自由现金流率PNTGRMBS
| Q1 26 | — | — | ||
| Q4 25 | 6.0% | 49.0% | ||
| Q3 25 | 4.6% | 46.2% | ||
| Q2 25 | 14.4% | 51.0% | ||
| Q1 25 | -11.1% | 41.7% | ||
| Q4 24 | 9.1% | 32.6% | ||
| Q3 24 | 3.8% | 35.9% | ||
| Q2 24 | 5.3% | 44.7% |
资本支出强度PNTGRMBS
| Q1 26 | — | — | ||
| Q4 25 | 1.2% | 3.4% | ||
| Q3 25 | 1.5% | 3.3% | ||
| Q2 25 | 1.4% | 3.8% | ||
| Q1 25 | 0.9% | 4.7% | ||
| Q4 24 | 1.8% | 4.0% | ||
| Q3 24 | 0.5% | 6.8% | ||
| Q2 24 | 1.0% | 8.6% |
现金转化率PNTGRMBS
| Q1 26 | — | — | ||
| Q4 25 | 2.43× | 1.56× | ||
| Q3 25 | 2.29× | 1.83× | ||
| Q2 25 | 4.89× | 1.63× | ||
| Q1 25 | -2.73× | 1.28× | ||
| Q4 24 | 3.57× | 0.95× | ||
| Q3 24 | 1.24× | 1.28× | ||
| Q2 24 | 1.84× | 1.95× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PNTG
| Home Health Subsegment | $136.2M | 47% |
| Hospice Subsegment | $97.1M | 34% |
| Private And Other | $36.4M | 13% |
| Medicare And Medicaid | $19.6M | 7% |
| Affiliated Entity | $2.2M | 1% |
RMBS
| Product revenue | $88.0M | 49% |
| Royalties | $69.6M | 39% |
| Contract and other revenue | $22.6M | 13% |
